Company Overview - Tongling Jieya Biotechnology Co., Ltd. was established in 1999 and specializes in the research, production, and sales of wet wipes, with over 20 years of industry experience [2]. - The company went public on the Shenzhen Stock Exchange's Growth Enterprise Market on December 3, 2021, and is steadily advancing its fundraising projects [2]. Financial Performance - For the first three quarters of 2025, the company reported a revenue of 565 million yuan and a net profit of 67.9031 million yuan [3]. - The growth in performance is attributed to an increase in orders from overseas clients, the realization of business scale effects, and continuous optimization of product structure [3]. Future Business Drivers - Future growth will primarily rely on two engines: deepening cooperation with existing international brand clients and the new market opportunities and localized supply advantages brought by the upcoming U.S. factory [3]. - The company has maintained stable orders from existing clients and is actively expanding its business with international brand clients in other regional markets [3]. Client Relationships and Pricing Mechanism - The company has strong stability in its relationships with major clients, which are predominantly well-known global enterprises [3]. - A pricing adjustment mechanism is in place to respond to fluctuations in raw material prices and exchange rates [3]. Competitive Advantages - The company has developed significant core competitive advantages in technology research and development, production processes, quality control, customer resources, and product variety through years of focused development in the wet wipes market [3]. U.S. Factory Development - The U.S. factory is currently under construction and is expected to be operational in 2026, primarily serving the North American market [3]. - Key investment risks associated with the U.S. factory include client audit approvals, potential delays in production timelines, and cultural differences impacting production efficiency [3]. Capacity Utilization and Capital Expenditure - The current capacity utilization rate is maintained at over 80%, with new capacity expected to be constructed within 3 to 6 months [4]. - The company’s dividend policy balances shareholder returns with developmental support, adjusting based on actual operating conditions and future funding needs [4].
洁雅股份(301108) - 2025年10月27日 投资者关系活动记录表